Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $158.91M | $225.58M | 50.22% | +$66.68M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 3,760,869 | 7,464,572 | +3,703,703 | $34.34M | $79.27M | 17.65% | +$44.94M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $32.05M | $67.87M | 15.11% | +$35.81M |
| Merus N V | 1,600,000 | 1,169,028 | -430,972 | $44.00M | $52.64M | 11.72% | +$8.64M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $26.93M | $23.86M | 5.31% | -$3.07M |